← The Wire
CUENasdaq
Cue Biopharma, Inc.
Pharmaceutical Preparations · DE · CIK 1645460
Developing injectable therapeutics to selectively engage and modulate disease-specific T cells for autoimmune and inflammatory diseases
red 8-K · 90d
$103M
Market cap
$30.43
Last close
+19.9%
1D
-1.0%
5D
164K
Volume
Price · last 39 sessions+1.9%
May 4L $20.03 · H $35.73Jun 29
176
Total filings
Jun 3, 2026
Last filing
12/31
Fiscal year end
DEF 14ADEF 14AMay 21, 2026DEF 14ADEF 14AMar 16, 2026DEF 14ADEF 14AApr 25, 2025DEF 14ADEF 14ASep 10, 2024DEF 14ADEF 14AApr 26, 2024DEF 14ADEF 14AApr 28, 2023DEF 14ADEF 14AApr 29, 2022DEF 14ADEF 14AApr 26, 2021DEF 14ADEF 14AMay 29, 2020DEF 14ADEF 14AJun 18, 2019DEF 14ADEF 14AApr 30, 2018
Insider Activity
In the 90 days to Dec 30, 2025: 1 insider bought $100K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Dec 30, 2025 | Sarraf PashaDirector | Buy | 86,947 | $0.32 | $28K |
| Dec 30, 2025 | Sarraf PashaDirector | Buy | 78,116 | $0.31 | $24K |
| Dec 30, 2025 | Sarraf PashaDirector | Buy | 77,417 | $0.30 | $23K |
| Dec 30, 2025 | Sarraf PashaDirector | Buy | 77,148 | $0.30 | $23K |
| Dec 30, 2025 | Sarraf PashaDirector | Buy | 4,229 | $0.31 | $1K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance